Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer

6 Apr 2023

Abstract excerpt

Breast cancer is the most commonly diagnosed cancer, and its global impact is increasing. Its onset and progression are influenced by multiple cues, one of which is the disruption of the internal circadian clock. Cryptochrome 2 (Cry2) genetic dysregulation may lead to the development of some diseases and even tumors. In addition, post-translational modifications can alter the Cry2 function. Here, we aimed to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circadian rhythm and melatonin
Share to Genomics, phytochemicals, and oxidative stress
Share to Sirtuins and Resveratrol in Medicine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37024472
DOI: 10.1038/s41419-023-05762-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancerPMID 37024472Read ↗

The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling.Semantic proximity Read ↗

Targeting circadian transcriptional programs through a cis-regulatory mechanism in triple negative breast cancerSemantic proximity Read ↗

A Novel CREBBP/p300 Activator, YF2, Enhances Cytotoxic and Immune-Mediated Responses in B-Cell LymphomaSemantic proximity Read ↗

Elucidation of clinical implications Arising from circadian rhythm and insights into the tumor immune landscape in breast cancerSemantic proximity Read ↗

Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapySemantic proximity Read ↗

Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2.Semantic proximity Read ↗

The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic targetSemantic proximity Read ↗

The circadian rhythm key gene ARNTL2: a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancersSemantic proximity Read ↗

Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain InhibitorsSemantic proximity Read ↗

PER1 as a Tumor Suppressor Attenuated in the Malignant Phenotypes of Breast Cancer CellsSemantic proximity Read ↗

The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancerSemantic proximity Read ↗

<i>CRY2</i> missense mutations suppress P53 and enhance cell growthSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.